HEALTH (ALT)

KWN HEALTH

HEALTH (MSM)

Jump in counselling for UK transgender children wins LGBT praise

By Kieran Guilbert LONDON (Thomson Reuters Foundation) – A growing number of children in Britain are being referred to the state-funded National Health Service (NHS) for counselling for transgender feelings, a development activists hailed on Wednesday as a sign of greater awareness of transgender issues. The number of children – under 11 and some as young as three – being treated at the country’s only specialist centre for children with

Jump in counseling for UK transgender children wins LGBT praise

By Kieran Guilbert LONDON (Thomson Reuters Foundation) – A growing number of children in Britain are being referred to the state-funded National Health Service (NHS) for counseling for transgender feelings, a development activists hailed on Wednesday as a sign of greater awareness of transgender issues. The number of children – under 11 and some as young as three – being treated at the country’s only specialist center for children with

U.N. warns of 'slaughter of innocents' in Syrian refugee camp

By Magdalena Mis LONDON (Thomson Reuters Foundation) – United Nations officials warned on Wednesday of a potential “slaughter of innocents” unless aid and assistance reached a Palestinian refugee camp in Syria where thousands of civilians are trapped up in a vicious battle. Some 18,000 civilians, including 3,500 children, are caught in the camp outside Damascus just a few miles from President Bashar al-Assad’s palace. The Yarmouk camp, which was home

Rural Women Access Early Cancer Screening in Turkey

Cross-posted from UN Women“I would not have found the opportunity to even go ,” says 65-year-old Ümmügül, from a farming family in the village of Hamamkarahisar, located an hour away from Eskişehir – a central Anatolian city in Turkey. She is one of the 659 rural women living on…

UK biotech Silence Therapeutics raises $58 million for its RNA drive

British biotech group Silence Therapeutics has raised 38.9 million pounds ($58.2 million) by selling two tranches of new shares at 240 pence each to develop its genetic medicine platform. The company, whose technology works by interfering with RNA molecules, said its brokers had sold an additional block of shares to institutions, meeting demand after an initial sale announced on April 2 raised 27.3 million pounds. Chief executive Ali Mortazavi said